Search results for: NICE
Filter search results
Join OHE at ISPOR: MCDA, Risk Sharing and Value-Based Pricing
4 October 2011
…will include Mark Sculpher, University of York; Stuart Peacock, University of British Columbia; and Carole Longson, NICE. Adrian Towse is a speaker at the first plenary session, ‘Pros and Cons…
Just Released: Health and the Use of Medicines in Wales
3 November 2011
…positive appraisals from NICE or from the All Wales Medicine Strategy Group. The report suggests that the increasing availability of generic medicines over the next few years could provide enough…
Spotlight on OHE: Measuring Preferences, HTA Benchmarking, Value-Based Pricing, and Rationing
13 October 2011
…your life’. Koonal’s presentation reported the findings from an initial phase of a larger study that explores whether the general public agrees with NICE’s policy of giving a higher priority…
Save the Date: Drug Development in 2022, OHE’s 50th Anniversary Conference
21 June 2012
…Chairman of the UK National Institute for Health and Clinical Excellence (NICE) The conference will be held in London on Monday, 8 October 2012, from 10.00 AM to 6.00 PM,…
Register Now for the OHE Conference on Drug Development in 2022
2 July 2012
…Professor of Economics and Management, IMT Institute For Advanced Studies Professor Sir Michael Rawlins, Chairman of the UK National Institute for Health and Clinical Excellence (NICE) Please see the full…
OHE Conference on Drug Development in 2022: Update
18 July 2012
…National Institute for Health and Clinical Excellence (NICE) Professor Adrian Towse, Director, Office of Health Economics For the full programme and to register, click here. Please note that discounted early-bird…
Register Now for the OHE Conference on Drug Development in 2022
14 August 2012
…those participating are Sir Alasdair Breckenridge from the MHRA, Dr Hans-Georg Eichler from the EMA, and Sir Michael Rawlins of NICE. For the full programme and to book your place,…
OHE Conference on the Future of Drug Development – Register Now
5 September 2012
…those participating are Sir Alasdair Breckenridge from the MHRA, Dr Hans-Georg Eichler from the EMA, and Sir Michael Rawlins of NICE. For the full programme and to book your place,…
Advances in Oncology Modelling: Recent Results from POI Research
18 September 2012
…Knight and Meindert Boysen from NICE. [1] The POI is a group of pharmaceutical companies, all members of the Association of the British Pharmaceutical Industry, that work with and support…